The Scientific Advisory and Development team at SalioGen Therapeutics focuses on advancing the company's EDIT platform through rigorous scientific research and strategic guidance. This multidisciplinary team, comprising directors, advisors, and scientists, collaborates to refine gene therapy processes and ensure the efficacy and safety of SalioGen's non-viral gene therapies, ultimately contributing to the development of potentially curative treatments.
View all